Ayurcann Holdings Corp. (CSE:AYUR) (CSE:AYUR), a Canadian cannabis extraction company specializing in the processing of cannabis and hemp for the production of oils and derivative products, said it has entered into a patient-referral agreement with ReLeave Therapeutics, a leader in providing expert guidance and access to managing discomfort with medicinal cannabis and other alternative medicines.
Under the partnership, ReLeave will send medical cannabis patients to Ayurcann through a patient education agreement. Ayurcann will work with the patients to educate them on their available offerings and help them select appropriate products.
"Working with the leaders in the industry is what we strive towards, being able to partner with and enhance cannabis education, provide the best possible value, national coverage while expanding our offerings for the best national and international brands for THC and CBD based products to patients is making Ayurcann and Ayurcann Marketplace a leader in the industry,” Ayurcann CEO Igal Sudman said in a statement.
READ: Ayurcann Holdings wins first purchase order from Saskatchewan
Ayurcann said ReLeave is comprised of experts whose goal is defined by providing exemplary patient care, which necessitates working with only the best healthcare partners.
The company helps integrate cannabis into the patient's full medical treatment plans and partners with medicinal cannabis providers such as Ayurcann to ensure their patients are getting top-quality advice with exceptional value and are being prescribed the right medicinal cannabis products for their needs.
"ReLeave started at a very uncertain time, which provided us with the opportunity to provide healthcare differently and in a more patient-centric way,” ReLeave CEO Greg Benson said.
“As the world around us changes, we strive to be leaders and innovators in providing patient care and working with Ayurcann and the Ayurcann Marketplace platform will enable us to excel."
Ayurcann Holdings is carving out a niche for itself in the cannabis industry with its post-harvest solutions for licensed producers. The company owns a B2B processing facility that provides services for Canadian licensed producers – anything from extraction and refinement to bulk oil sales and white label manufacturing.
Contact the author at stephen.gunnion@proactiveinvestors.com